Showing results (151-160 of 247) with videos related to
Sort By:
Pageof 25
International Journal of Molecular Imaging|July 15, 2011
Synthesis and in vitro evaluation of novel nortropane derivatives as potential radiotracers for muscarinic m(2) receptorsRemco J J Knol, Jan C van den Bos, Anton G M Janssen, et al.Parkinsonism & Related Disorders|January 24, 2026
Automated assessment of susceptibility map-weighted imaging in patients with clinically uncertain parkinsonismElon D Wallert, Elsmarieke van de Giessen, Martijn Beudel, et al.Journal of Medicinal Chemistry|December 12, 2013
Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D₂/₃ receptors in their high-affinity stateJan-Peter van Wieringen, Vladimir Shalgunov, Henk M Janssen, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2014
Dopaminergic system dysfunction in recreational dexamphetamine usersAnouk Schrantee, Lena Václavů, Dennis F R Heijtel, et al.Neuroradiology|September 28, 2022
Acceleration of neuromelanin-sensitive MRI sequences in the substantia nigra using standard MRI optionsMarieke van der Pluijm, Elon D Wallert, Bram F Coolen, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 11, 2017
The effect of the muscarinic M<sub>1</sub> receptor antagonist biperiden on cognition in medication free subjects with psychosisClaudia Vingerhoets, Geor Bakker, Jelske van Dijk, et al.Journal of Medicinal Chemistry|April 28, 2011
Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinated analogues of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptorRana Al Hussainy, Joost Verbeek, Dion van der Born, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 6, 2014
Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PETVladimir Shalgunov, Jan-Peter van Wieringen, Henk M Janssen, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 20, 2009
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2Andrea Varrone, Susanne Asenbaum, Thierry Vander Borght, et al.EJNMMI Research|October 23, 2022
Comparison of [<sup>18</sup>F]-FDOPA PET and [<sup>123</sup>I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndromeElon Wallert, Erwann Letort, Friso van der Zant, et al.Pageof 25